Research Article
BibTex RIS Cite

Assessing the gastroprotective effects of pioglitazone by determining its effect on TNF-α and SOD levels on indomethacin-induced gastric ulcer in a rat model

Year 2025, Volume: 29 Issue: 6, 2464 - 2475, 02.11.2025
https://doi.org/10.12991/jrespharm.1798118

Abstract

Gastric ulcer is the predominant gastrointestinal condition, accounting for approximately 20% of peptic ulcers. The current study aimed to investigate the prophylactic effects of pioglitazone on histology, severity of gastric ulcers and levels of inflammatory and antioxidant markers that include tumor necrosis factor alpha (TNF-α) and superoxide dismutase (SOD) on fifty healthy male albino rats weighing 150-250g divided into five groups including negative control group received only vehicle, positive control group received indomethacin orally (60 mg/kg), third group received oral omeprazole solution (20 mg/kg) 30 minutes before indomethacin solution induction, fourth group received oral 30mg/kg pioglitazone solution 1-hour before indomethacin-induction, while the fifth group received oral pioglitazone and after 1-hour rats were administered oral omeprazole solution and waited for 30 minutes before indomethacin solution induction. The levels of TNF-α, SOD in addition to histological examination that include lesions number and damage score for all studied groups. Results demonstrated that rats received combination of Pioglitazone and omeprazole showed a statistically significant (p<0.05) reduction in the severity of stomach ulcers and histological damage score. The administration of pioglitazone at a dose of 30 mg/kg to the pre-treated group reduced the levels of TNF-α and SOD to an extent similar to those observed with the reference medication with a significant improvement in the histological markers which indicate that pioglitazone showed a Cytoprotective and gastroprotective effect against ulcerations induced by indomethacin and support the suggestions of using it in the ulcer treatment either alone or in combination with standard treatments.

References

  • [1] Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017;390(10094):613-624. https://doi.org/10.1016/s0140- 6736(16)32404-7
  • [2] Masoodi M, Sabzikarian M, Masoodi N, Farhadi S, Rezamand GR, Tabaeian SP, Talebi A, Fayyaz F. Peptic ulcer characteristics in oral opium and non-opium user patients with upper gastrointestinal bleeding. BMC Gastroenterol. 2024;24(1):42. https://doi.org/10.1186/s12876-024-03137-7
  • [3] De Jesus NZT, Falcão HS, Gomes IF, Leite TJA, Lima GRM, Barbosa-Filho JM, Tavares JF, Silva MSD, AthaydeFilho PF, Batista LM. Tannins, peptic ulcers and related mechanisms. Int J Mol Sci. 2012;13(3):3203-3228. https://doi.org/10.3390/ijms13033203
  • [4] Bandyopadhyay D, Chattopadhyay A. Reactive oxygen species-induced gastric ulceration: protection by melatonin. Curr Med Chem. 2006;13(10):1187-1202. https://doi.org/10.2174/092986706776360842
  • [5] Al-Marsoumi AM, Jabbo NS. Risk factors in perforated peptic ulcer disease: Incidence and relation to morbidity and mortality. Mustansiriya Med J. 2013;12(1):35–44.
  • [6] Al-Marzooq TJ, Naji RE, Al-Majidi AK, Abbas Y. The use of serum amylase as a predictive factor for mortality in perforated duodenal ulcer. J Fac Med Baghdad. 2015;57(4):295–298. https://doi.org/10.32007/jfacmedbagdad.574393
  • [7] Malaty HM. Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol. 2007;21(2):205-214. https://doi.org/10.1016/j.bpg.2006.10.005
  • [8] Szeto CC, Sugano K, Wang JG, Fujimoto K, Whittle S, Modi GK, Chen CH, Park JB, Tam LS, Vareesangthip K, Tsoi KKF, Chan FKL. Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations. Gut. 2020;69(4):617-629. https://doi.org/10.1136/gutjnl-2019-319300
  • [9] Ali MK. The isolation and identification of H. pylori among Iraq patients with chronic gastric inflammation. J Fac Med Baghdad. 2022;64(2):102–108. https://doi.org/10.32007/jfacmedbagdad.6421929
  • [10] Manna MJ, Matloub SYN. Cytoprotective actions of omeprazole in indomethacin–induced gastric mucosal injury in rats. J Fac Med Baghdad. 2010;52(1):80–84. https://doi.org/10.32007/jfacmedbagdad.5211064
  • [11] Matloub SYN, Manna MJ. The cytoprotective effect of different doses of Sildenafil on indomethacin-induced gastric mucosal damage in rats. J Fac Med Baghdad. 2010;52(4):426–431. https://doi.org/10.32007/jfacmedbagdad.524950
  • [12] Matloub SYN. Captopril versus enalapril in the protection of the gastric mucosa against NSAID induced gastric mucosal injury in rats. J Fac Med Baghdad. 2011;53(2):236–240. https://doi.org/10.32007/jfacmedbagdad.532882
  • [13] Waugh J, Keating GM, Plosker GL, Easthope S, Robinson DM. Pioglitazone: a review of its use in type 2 diabetes mellitus. Drugs. 2006;66(1):85-109. https://doi.org/10.2165/00003495-200666010-00005
  • [14] Akram W, Taha I, Saieed WN. The use of oral thiazoldinediones in correction of hormonal abnormalities among unmarried women with resistant PCO. J Fac Med Baghdad. 2006;48(4):378–382. https://doi.org/10.32007/jfacmedbagdad.4841455
  • [15] Drini M. Peptic ulcer disease and non-steroidal anti-inflammatory drugs. Aust Prescr. 2017;40(3):91-93. https://doi.org/10.18773/austprescr.2017.037
  • [16] Song H, Hou X, Zeng M, Chen X, Chen X, Yang T, Xu F, Peng J, Peng Q, Cai X, Yu R. Traditional Chinese Medicine Li-Zhong-Tang accelerates the healing of indomethacin-induced gastric ulcers in rats by affecting TLR-2/MyD88 signaling pathway. J Ethnopharmacol. 2020;259:112979. https://doi.org/10.1016/j.jep.2020.112979
  • [17] Matah Marte VM, Ateufack G, Mbiantcha M, Atsamo AD, Adjouzem CF, Djuichou Nguemnang SF, Tsafack EG, Yousseu Nana W, Madjo Kouam YK, Ngoufack Azanze E. Methanolic extract of Distemonanthus benthamianus (Caesalpiniaceae) stem bark suppresses ethanol/ındomethacin-ınduced chronic gastric ınjury in rats. Gastroenterol Res Pract. 2020;2020:8180323. https://doi.org/10.1155/2020/8180323
  • [18] Hamauzu Y, Irie M, Kondo M, Fujita T. Antiulcerative properties of crude polyphenols and juice of apple, and Chinese quince extracts. Food Chem. 2008;108(2):488-495. https://doi.org/10.1016/j.foodchem.2007.10.084
  • [19] Minaiyan M, Sajjadi SE, Amini K. Antiulcer effects of Zataria multiflora Boiss. on indomethacin-induced gastric ulcer in rats. Avicenna J Phytomed. 2018;8(5):408-415.
  • [20] Maity P, Bindu S, Dey S, Goyal M, Alam A, Pal C, Mitra K, Bandyopadhyay U. Indomethacin, a non-steroidal antiinflammatory drug, develops gastropathy by inducing reactive oxygen species-mediated mitochondrial pathology and associated apoptosis in gastric mucosa: a novel role of mitochondrial aconitase oxidation. J Biol Chem. 2009 ;284(5):3058-3068. https://doi.org/10.1074/jbc.m805329200
  • [21] Sabiu S, Garuba T, Sunmonu T, Ajani E, Sulyman A, Nurain I, Balogun A. Indomethacin-induced gastric ulceration in rats: Protective roles of Spondias mombin and Ficus exasperata. Toxicol Rep. 2015;2:261-267. https://doi.org/10.1016/j.toxrep.2015.01.002
  • [22] Antonisamy P, Arasu MV, Dhanasekaran M, Choi KC, Aravinthan A, Kim NS, Kang CW, Kim JH. Protective effects of trigonelline against indomethacin-induced gastric ulcer in rats and potential underlying mechanisms. Food Funct. 2016;7(1):398-408. https://doi.org/10.1039/c5fo00403a
  • [23] Küçükler S, Kandemir FM, Yıldırım S. Protective effect of chrysin on indomethacin induced gastric ulcer in rats: role of multi-pathway regulation. Biotech Histochem. 2022;97(7):490- 503. https://doi.org/10.1080/10520295.2021.2014569
  • [24] Brzozowski T, Konturek PC, Konturek SJ, Kwiecien S, Pajdo R, Karczewska E, Stachura J, Hahn EG. Water extracts of Helicobacter pylori delay healing of chronic gastric ulcers in rats: role of cytokines and gastrin-somatostatin link. Digestion. 1999;60(1):22-33. https://doi.org/10.1159/000007585
  • [25] Shimizu N, Watanabe T, Arakawa T, Fujiwara Y, Higuchi K, Kuroki T. Pentoxifylline accelerates gastric ulcer healing in rats: roles of tumor necrosis factor alpha and neutrophils during the early phase of ulcer healing. Digestion. 2000;61(3):157-164. https://doi.org/10.1159/000007752
  • [26] Allami N, Javadi-Paydar M, Rayatnia F, Sehhat K, Rahimian R, Norouzi A, Dehpour AR. Suppression of nitric oxide synthesis by L-NAME reverses the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice. Eur J Pharmacol. 2011;650(1):240-248. https://doi.org/10.1016/j.ejphar.2010.10.007
  • [27] Heneka MT, Sastre M, Dumitrescu-Ozimek L, Hanke A, Dewachter I, Kuiperi C, O'Banion K, Klockgether T, Van Leuven F, Landreth GE. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Brain. 2005;128(Pt 6):1442-1453. https://doi.org/10.1093/brain/awh452
  • [28] Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G, Glass CK. 15-deoxydelta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci U S A. 2000;97(9):4844-4849. https://doi.org/10.1073/pnas.97.9.4844
  • [29] Moezi L, Janahmadi Z, Amirghofran Z, Nekooeian AA, Dehpour AR. The increased gastroprotective effect of pioglitazone in cholestatic rats: role of nitric oxide and tumour necrosis factor alpha. Int J Exp Pathol. 2014;95(1):78- 85. https://doi.org/10.1111/iep.12067
  • [30] Suzuki H, Nishizawa T, Tsugawa H, Mogami S, Hibi T. Roles of oxidative stress in stomach disorders. J Clin Biochem Nutr. 2012;50(1):35-39. https://doi.org/10.3164/jcbn.11-115sr
  • [31] Hatware KV, Sharma S, Patil K, Shete M, Karri S, Gupta G. Evidence for gastroprotective, anti-inflammatory and antioxidant potential of methanolic extract of Cordia dichotoma leaves on indomethacin and stress induced gastric lesions in Wistar rats. Biomed Pharmacother. 2018;103:317-325. https://doi.org/10.1016/j.biopha.2018.04.007
  • [32] Saiah W, Halzoune H, Djaziri R, Tabani K, Koceir EA, Omari N. Antioxidant and gastroprotective actions of butanol fraction of Zingiber officinale against diclofenac sodium‐induced gastric damage in rats. J Food Biochem. 2018;42(1):e12456. http://dx.doi.org/10.1111/jfbc.12456
  • [33] Moezi L, Heidari R, Amirghofran Z, Nekooeian AA, Monabati A, Dehpour AR. Enhanced anti-ulcer effect of pioglitazone on gastric ulcers in cirrhotic rats: the role of nitric oxide and IL-1β. Pharmacol Rep. 2013;65(1):134- 143. https://doi.org/10.1016/s1734-1140(13)70971-x
  • [34] Shahin NN, Abdelkader NF, Safar MM. A novel role of irbesartan in gastroprotection against ındomethacinınduced gastric ınjury in rats: Targeting DDAH/ADMA and EGFR/ERK Signaling. Sci Rep. 2018;8(1):4280. https://doi.org/10.1038/s41598-018-22727-6
  • [35] Altuner D, Kaya T, Suleyman H. The protective effect of lercanidipine on indomethacin-induced gastric ulcers in rats. Brazilian Arch Biol Technol. 2020;63:e20190311. http://dx.doi.org/10.1590/1678-4324-2020190311
  • [36] Veilleux-Lemieux D, Castel A, Carrier D, Beaudry F, Vachon P. Pharmacokinetics of ketamine and xylazine in young and old Sprague-Dawley rats. J Am Assoc Lab Anim Sci. 2013;52(5):567-570.
  • [37] Zhanmu O, Yang X, Gong H, Li X. Paraffin-embedding for large volume bio-tissue. Sci Rep. 2020;10(1):12639. https://doi.org/10.1038/s41598-020-68876-5
  • [38] Carll AP, Willis MS, Lust RM, Costa DL, Farraj AK. Merits of non-invasive rat models of left ventricular heart failure. Cardiovasc Toxicol. 2011;11(2):91-112. https://doi.org/10.1007/s12012-011-9103-5
  • [39] Aldafaay AAA, Abdulamir HA, Abdulhussain HA, Badry AS, Abdulsada AK. The use of Urinary α-amylase level in a diagnosis of chronic renal failure. Res J Pharm Technol. 2021; 14(3):1597-1600. http://dx.doi.org/10.5958/0974- 360X.2021.00283.3
  • [40] Manna MJ, Baqir LS, Abdulamir HA. The assessment of the antimicrobial effect of gemfibrozil alone or in combination with ceftriaxone or gentamycin on several types of bacteria. Acta Pharm Sci. 2024;62(3):565-574. http://dx.doi.org/10.23893/1307-2080.APS6235
There are 40 citations in total.

Details

Primary Language English
Subjects Pharmacology and Pharmaceutical Sciences (Other)
Journal Section Articles
Authors

Hela Muayed Abd-Alqhani This is me 0009-0005-8261-9580

Huda I. Alqadhi This is me 0000-0003-2100-9728

Publication Date November 2, 2025
Submission Date September 10, 2024
Acceptance Date November 9, 2024
Published in Issue Year 2025 Volume: 29 Issue: 6

Cite

APA Abd-Alqhani, H. M., & Alqadhi, H. I. (2025). Assessing the gastroprotective effects of pioglitazone by determining its effect on TNF-α and SOD levels on indomethacin-induced gastric ulcer in a rat model. Journal of Research in Pharmacy, 29(6), 2464-2475. https://doi.org/10.12991/jrespharm.1798118
AMA Abd-Alqhani HM, Alqadhi HI. Assessing the gastroprotective effects of pioglitazone by determining its effect on TNF-α and SOD levels on indomethacin-induced gastric ulcer in a rat model. J. Res. Pharm. November 2025;29(6):2464-2475. doi:10.12991/jrespharm.1798118
Chicago Abd-Alqhani, Hela Muayed, and Huda I. Alqadhi. “Assessing the Gastroprotective Effects of Pioglitazone by Determining Its Effect on TNF-α and SOD Levels on Indomethacin-Induced Gastric Ulcer in a Rat Model”. Journal of Research in Pharmacy 29, no. 6 (November 2025): 2464-75. https://doi.org/10.12991/jrespharm.1798118.
EndNote Abd-Alqhani HM, Alqadhi HI (November 1, 2025) Assessing the gastroprotective effects of pioglitazone by determining its effect on TNF-α and SOD levels on indomethacin-induced gastric ulcer in a rat model. Journal of Research in Pharmacy 29 6 2464–2475.
IEEE H. M. Abd-Alqhani and H. I. Alqadhi, “Assessing the gastroprotective effects of pioglitazone by determining its effect on TNF-α and SOD levels on indomethacin-induced gastric ulcer in a rat model”, J. Res. Pharm., vol. 29, no. 6, pp. 2464–2475, 2025, doi: 10.12991/jrespharm.1798118.
ISNAD Abd-Alqhani, Hela Muayed - Alqadhi, Huda I. “Assessing the Gastroprotective Effects of Pioglitazone by Determining Its Effect on TNF-α and SOD Levels on Indomethacin-Induced Gastric Ulcer in a Rat Model”. Journal of Research in Pharmacy 29/6 (November2025), 2464-2475. https://doi.org/10.12991/jrespharm.1798118.
JAMA Abd-Alqhani HM, Alqadhi HI. Assessing the gastroprotective effects of pioglitazone by determining its effect on TNF-α and SOD levels on indomethacin-induced gastric ulcer in a rat model. J. Res. Pharm. 2025;29:2464–2475.
MLA Abd-Alqhani, Hela Muayed and Huda I. Alqadhi. “Assessing the Gastroprotective Effects of Pioglitazone by Determining Its Effect on TNF-α and SOD Levels on Indomethacin-Induced Gastric Ulcer in a Rat Model”. Journal of Research in Pharmacy, vol. 29, no. 6, 2025, pp. 2464-75, doi:10.12991/jrespharm.1798118.
Vancouver Abd-Alqhani HM, Alqadhi HI. Assessing the gastroprotective effects of pioglitazone by determining its effect on TNF-α and SOD levels on indomethacin-induced gastric ulcer in a rat model. J. Res. Pharm. 2025;29(6):2464-75.